By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ExThera Medical 



Stockholm      Sweden
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Medical Device






Company News
ExThera Medical Publishes Results Of "CRE Superbug" Binding Study: A Device-Based Therapy For Drug-resistant Bacterial Infections Is Now Possible 12/4/2014 9:24:52 AM
ExThera Medical Posts $3.75 Million First Closing Of Its $7 Million Convertible Note Offering 10/6/2014 10:52:35 AM
ExThera Medical Appoints John W. Feik To Its Board Of Directors 9/12/2014 10:09:47 AM
U.S. Patent No. 8,758,286 Issued To ExThera Medical, Whose Seraph® Technology Is Designed To Combat Drug-Resistant "Superbugs" 6/24/2014 10:37:55 AM
ExThera Medical and BioBridge Global Will Collaborate in Research Program to Apply ExThera’s Seraph® Microbind® Technology for Removal of Bacterial and Viral Threats to Global Blood Supply 10/1/2013 10:02:13 AM
Company Profile for ExThera Medical 9/27/2013 9:22:36 AM
ExThera Medical’s CEO Bob Ward to Present at ‘OneMedForum 2013’ Next Week in San Francisco 1/3/2013 8:54:10 AM
ExThera Medical’ Seraph™ Microbind™ Affinity Blood Filter Demonstrates Potential for Reducing High Death Rate From Sepsis, a Top-10 Cause of Death in the U.S. 9/10/2012 9:24:51 AM
ExThera Medical Appoints Medical Advisory Board 1/9/2012 11:01:49 AM
ExThera Medical Appoints Medical Advisory Board 1/9/2012 8:03:14 AM
12
//-->